Recent molecular researches have revealed PIK3CA mutations in 7–33% of Br-NENs, although the frequency is lower than that reported in HR-positive HER2-negative IBC-NSTs [51,52,53,54]. This evidence concerns the gene ERBB2 and inflammatory breast carcinoma.